Dwight Reynolds to Humans
This is a "connection" page, showing publications Dwight Reynolds has written about Humans.
Connection Strength
0.660
-
Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter Pacing Study. Pacing Clin Electrophysiol. 2017 Jul; 40(7):834-842.
Score: 0.033
-
Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665.
Score: 0.032
-
A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016 06 30; 374(26):2604-5.
Score: 0.031
-
A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016 Feb 11; 374(6):533-41.
Score: 0.029
-
Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1402-8.
Score: 0.025
-
Apparent acute reversible right ventricular pacing-induced left ventricular dysfunction. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):224-6.
Score: 0.024
-
Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace. 2012 Oct; 14(10):1490-7.
Score: 0.023
-
Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. J Natl Med Assoc. 2012 May-Jun; 104(5-6):287-98.
Score: 0.023
-
Prevention of cardiovascular events by treating hypertension in older adults: an evidence-based approach. J Clin Hypertens (Greenwich). 2008 Mar; 10(3):219-25.
Score: 0.017
-
New concepts in physiologic cardiac pacing. Curr Cardiol Rep. 2007 Sep; 9(5):351-7.
Score: 0.017
-
Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana. Heart Rhythm. 2005 Sep; 2(9):1025-33.
Score: 0.014
-
Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol. 2005 Mar; 28(3):235-40.
Score: 0.014
-
A new paradigm of cardiovascular risk factor modification. Vasc Health Risk Manag. 2005; 1(2):101-9.
Score: 0.014
-
The evolving challenge of chronic heart failure management: a call for a new curriculum for training heart failure specialists. J Am Coll Cardiol. 2004 Oct 06; 44(7):1354-7.
Score: 0.014
-
Sinus node dysfunction in a heart transplant patient secondary to severe sinus node artery obstruction--a case report. Angiology. 2003 Nov-Dec; 54(6):725-8.
Score: 0.013
-
Interventions in the diagnosis and adoption of pacemaker therapy in sinus node dysfunction patients: Results from the IMPROVE Brady study. Indian Heart J. 2022 Sep-Oct; 74(5):351-356.
Score: 0.012
-
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker. Europace. 2022 07 21; 24(7):1119-1126.
Score: 0.012
-
Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace. 2019 Nov 01; 21(11):1686-1693.
Score: 0.010
-
Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. Pacing Clin Electrophysiol. 2019 08; 42(8):1105-1110.
Score: 0.009
-
Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019 04; 30(4):569-574.
Score: 0.009
-
Health-related quality of life impact of a transcatheter pacing system. J Cardiovasc Electrophysiol. 2018 12; 29(12):1697-1704.
Score: 0.009
-
Physical activity detection in patients with intracardiac leadless pacemaker. J Cardiovasc Electrophysiol. 2018 12; 29(12):1690-1696.
Score: 0.009
-
NASPE expert consensus statement: physician workforce in cardiac electrophysiology and pacing. NASPE task force, Washington, D.C. Pacing Clin Electrophysiol. 1998 Aug; 21(8):1646-55.
Score: 0.009
-
To retrieve, or not to retrieve: System revisions with the Micra transcatheter pacemaker. Heart Rhythm. 2017 12; 14(12):1801-1806.
Score: 0.008
-
Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 07; 38(10):730-738.
Score: 0.008
-
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017 05; 14(5):702-709.
Score: 0.008
-
Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. Heart Rhythm. 2017 05; 14(5):685-691.
Score: 0.008
-
Rate adaptive pacing in an intracardiac pacemaker. Heart Rhythm. 2017 02; 14(2):200-205.
Score: 0.008
-
Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol. 2016 07; 27(7):827-32.
Score: 0.008
-
Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015 Oct 01; 36(37):2510-9.
Score: 0.007
-
The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker. Europace. 2015 May; 17(5):807-13.
Score: 0.007
-
Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol. 1995 Apr; 25(5):1176-82.
Score: 0.007
-
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. J Am Coll Cardiol. 2014 Aug 26; 64(8):797-807.
Score: 0.007
-
Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial. Am Heart J. 2014 Apr; 167(4):429-36.
Score: 0.006
-
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Circ Heart Fail. 2014 Jan; 7(1):146-53.
Score: 0.006
-
The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jan; 25(1):43-51.
Score: 0.006
-
The right atrial free wall: an alternative pacing site. Pacing Clin Electrophysiol. 1993 May; 16(5 Pt 1):959-63.
Score: 0.006
-
Kissing balloon technique in complex PTCA: single guiding catheter and dual wire rapid exchange system. Cathet Cardiovasc Diagn. 1993 Apr; 28(4):358-60.
Score: 0.006
-
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF. Pacing Clin Electrophysiol. 2013 Apr; 36(4):433-43.
Score: 0.006
-
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7.
Score: 0.006
-
Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clin Cardiol. 2012 Mar; 35(3):187-96.
Score: 0.006
-
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012 Jan; 163(1):49-56.e2.
Score: 0.006
-
Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. Pacing Clin Electrophysiol. 2012 Feb; 35(2):135-45.
Score: 0.006
-
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012 Jan-Feb; 18(1):9-17.
Score: 0.005
-
Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011 Apr 19; 123(15):1601-10.
Score: 0.005
-
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). Am J Cardiol. 2011 Jan 15; 107(2):250-8.
Score: 0.005
-
Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. J Card Fail. 2010 Dec; 16(12):940-9.
Score: 0.005
-
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010 Aug 10; 122(6):585-96.
Score: 0.005
-
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
Score: 0.005
-
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol. 2010 Jun 15; 105(12):1773-9.
Score: 0.005
-
Electronic health records and quality of care for heart failure. Am Heart J. 2010 Apr; 159(4):635-642.e1.
Score: 0.005
-
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010 Apr 15; 105(8):1140-6.
Score: 0.005
-
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Am Heart J. 2010 Feb; 159(2):238-44.
Score: 0.005
-
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010 Jan 15; 105(2):255-60.
Score: 0.005
-
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009 Dec; 158(6):956-64.
Score: 0.005
-
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009 Dec; 6(12):1727-34.
Score: 0.005
-
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009 Apr; 157(4):754-62.e2.
Score: 0.005
-
Heart Rhythm Society Policy Statement Update: Recommendations on the Role of Industry Employed Allied Professionals (IEAPs). Heart Rhythm. 2008 Nov; 5(11):e8-10.
Score: 0.004
-
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm. 2008 Jun; 5(6):907-25.
Score: 0.004
-
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008 Jul; 1(2):98-106.
Score: 0.004
-
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007 Jul; 154(1):12-38.
Score: 0.004
-
Addendum to the clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm. 2005 Oct; 2(10):1161-3.
Score: 0.004
-
Implant experience with an implantable hemodynamic monitor for the management of symptomatic heart failure. Pacing Clin Electrophysiol. 2005 Aug; 28(8):747-53.
Score: 0.004
-
Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm. 2004 Sep; 1(3):371-5.
Score: 0.003
-
NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol. 2003 Jul; 26(7 Pt 1):1556-62.
Score: 0.003
-
Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003 Feb 19; 41(4):565-71.
Score: 0.003
-
Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail. 2002 Apr; 8(2):63-70.
Score: 0.003
-
Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol. 2002 Feb; 13(2):144-50.
Score: 0.003
-
The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol. 2002 Feb; 25(2):260-4.
Score: 0.003
-
Unexpectedly high defibrillation thresholds in an active can implantable cardioverter defibrillator system. Pacing Clin Electrophysiol. 2001 Jul; 24(7):1168-9.
Score: 0.003
-
Activated factor VII levels in patients with angiographically confirmed coronary artery disease. Am J Cardiol. 1997 Jul 15; 80(2):217-9.
Score: 0.002
-
Interference with cardiac pacemakers by cellular telephones. N Engl J Med. 1997 May 22; 336(21):1473-9.
Score: 0.002
-
Fibrinogen levels in women having coronary angiography. Am J Cardiol. 1996 Jul 01; 78(1):15-8.
Score: 0.002
-
PVC's versus SDC's. N Engl J Med. 1971 Jun 03; 284(22):1270-1.
Score: 0.001
-
Cross-talk in bipolar pacemakers. Pacing Clin Electrophysiol. 1989 Oct; 12(10):1613-21.
Score: 0.001
-
Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation. Circulation. 1983 Nov; 68(5):906-16.
Score: 0.001